Analysis of Complications After Robot-Assisted Radical Cystectomy Between 2002-2021.

Journal: Urology
Published Date:

Abstract

OBJECTIVE: To identify trends in complications following robot-assisted radical cystectomy (RARC) using a multi-institutional database, the International Robotic Cystectomy Consortium (IRCC).

Authors

  • Holly Ann Houenstein
    Roswell Park Comprehensive Cancer Center.
  • Zhe Jing
    1 A.T.L.A.S (Applied Technology Laboratory for Advanced Surgery) Program, Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Ahmed S Elsayed
    1 A.T.L.A.S (Applied Technology Laboratory for Advanced Surgery) Program, Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Yousuf O Ramahi
    Department of Urology, A.T.L.A.S (Applied Technology Laboratory for Advanced Surgery) Program, Roswell Park Comprehensive Cancer Center, Elm & Carlton St Buffalo, Buffalo, NY, 14263, USA.
  • Michael Stöckle
    University of the Saarland, Homburg Saar, Germany.
  • Carl Wijburg
    Department of Urology, Robotic Surgery, Rijnstate Hospital, Arnhem, The Netherlands.
  • Abolfazl Hosseini
  • Peter Wiklund
    Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Eric Kim
  • Jihad Kaouk
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. Electronic address: kaoukj@ccf.org.
  • Prokar Dasgupta
  • Mohammed S Khan
    Guy's Hospital.
  • Andrew A Wagner
    Department of Urology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Johar R Syed
    Henry Ford Health System.
  • James O Peabody
    Vattikuti Urology Institute, Center for Outcomes Research Analytics and Evaluation, Henry Ford Health System, Detroit, MI, USA.
  • Ketan Badani
    Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Lee Richstone
    Arthur Smith Institute for Urology, New York, NY.
  • Alexandre Mottrie
    ORSI Academy Melle Belgium.
  • Thomas J Maatman
    Metro Health Hospital, Wyoming, Michigan, USA.
  • Derya Balbay
    Koç University Hospital, Istanbul, Turkey.
  • Juan P Redorta
    Fundacio Puigvert.
  • Koon Ho Rha
    Department of Urology, Yonsei University College of Medicine, Seoul, Korea.
  • Franco Gaboardi
    Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Morgan Rouprêt
    Centre de Recherche sur les Pathologies Prostatiques, Paris, France; GRC No. 5 Predictive Onco-Urology, Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France.
  • Ahmed Aboumohamed
    Montefiore Medical Center (Albert Einstein College of Medicine), New York, NY.
  • Ahmed A Hussein
    Department of Urology, Applied Technology Laboratory for Advanced Surgery (ATLAS) Program at Roswell Park Cancer Institute, Buffalo, NY; Department of Urology, Cairo University, Cairo, Egypt.
  • Khurshid A Guru